Physician profile
Joseph Capre
NPI 1679644512
$722.96
in general payments reported to CMS, 2019-2025
8 companies · $97.03 in 2025
The $97.03 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $15.38 · 2020: $18.08 · 2021: $77.31 · 2022: $67.59 · 2023: $146 · 2024: $301 · 2025: $97.03.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $545.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $544.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eli Lilly Export S.A. Puerto Rico Branch | $227.60 | 2024-2025 | Zepbound, Mounjaro |
| Hologic Sales and Service, LLC | $167.43 | 2021-2025 | Thinprep 2000 Processor, Aptima |
| Johnson and Johnson International | $106.45 | 2023 | Megadyne, Dermabond Prineo, Stratafix |
| Roche Diagnostics Corporation | $75.86 | 2022-2024 | Cobas 4800 Ct/Ng Test V2.0 |
| Gen-Probe, INC. | $55.43 | 2021 | |
| Merck Sharp & Dohme LLC | $40.00 | 2023 | Gardasil 9 |
| Abbvie INC. | $33.46 | 2019-2020 | |
| Pbg Puerto Rico LLC | $16.73 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Capre listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.